Appropriate use of triazolam in elderly patients considering a quantitative benefit-risk assessment based on the pharmacokinetic-pharmacodynamic modeling and simulation approach supported by real-world data-Reference-Cited by-同舟云学术

Appropriate use of triazolam in elderly patients considering a quantitative benefit-risk assessment based on the pharmacokinetic-pharmacodynamic modeling and simulation approach supported by real-world data

Published:2024-09-03 Issue:1 Volume:25 Page:
ISSN:2050-6511
Container-title:BMC Pharmacology and Toxicology
language:en
Short-container-title:BMC Pharmacol Toxicol

Author:

Okada Akira^ORCID,Sera Shoji,Nagai Naomi

Funder

Japan Society for the Promotion of Science

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1186/s40360-024-00777-z.pdf

Reference41 articles.

1. Mangoni AA, Jackson SH. Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol. 2004;57(1):6–14.

2. Tanigawara Y. Recent advances in pharmacokinetics in elderly. Nihon Ronen Igakkai Zasshi. 2003;40(2):109–19.

3. Schlender JF, Meyer M, Thelen K, Krauss M, Willmann S, Eissing T, et al. Development of a whole-body physiologically based Pharmacokinetic Approach to assess the pharmacokinetics of drugs in Elderly individuals. Clin Pharmacokinet. 2016;55(12):1573–89.

4. Gutiérrez-Valencia M, Izquierdo M, Malafarina V, Alonso-Renedo J, González-Glaría B, Larrayoz-Sola B, et al. Impact of hospitalization in an acute geriatric unit on polypharmacy and potentially inappropriate prescriptions: a retrospective study. Geriatr Gerontol Int. 2017;17(12):2354–60.

5. Kojima T, Akishita M, Kameyama Y, Yamaguchi K, Yamamoto H, Eto M, et al. High risk of adverse drug reactions in elderly patients taking six or more drugs: analysis of inpatient database. Geriatr Gerontol Int. 2012;12(4):761–2.